61 results on '"Wauters, Els"'
Search Results
2. Lower respiratory tract single-cell RNA sequencing and neutrophil extracellular trap profiling of COVID-19-associated pulmonary aspergillosis: a single centre, retrospective, observational study
3. Trial watch: chemotherapy-induced immunogenic cell death in oncology
4. Visualising SARS-CoV-2 infection of the lung in deceased COVID-19 patients
5. C5aR1 signaling triggers lung immunopathology in COVID-19 through neutrophil extracellular traps
6. Position statement on the management of the immune checkpoint inhibitor-induced colitis via multidisciplinary modified Delphi consensus
7. Treatment of unresectable stage III NSCLC: Real world cohort study and literature review
8. Radiologic and Histologic Correlates of Early Interstitial Lung Changes in Explanted Lungs
9. Bronchoalveolar Lavage Fluid-Isolated Biomarkers for the Diagnostic and Prognostic Assessment of Lung Cancer
10. Case report: BRAF A598-T599insV mutation as a potential resistance mechanism to alectinib in ALK-rearranged lung adenocarcinoma
11. Incidence of Cardiovascular Events in Patients Treated With Immune Checkpoint Inhibitors
12. Severe COVID-19 patients display hyper-activated NK cells and NK cell-platelet aggregates
13. Acute kidney injury in patients receiving pembrolizumab combination therapy versus pembrolizumab monotherapy for advanced lung cancer
14. Hemolytic anemia caused by alectinib, an Anaplastic Lymphoma Kinase (ALK) inhibitor: A case report
15. Single-cell transcriptomics identifies pathogenic T-helper 17.1 cells and pro-inflammatory monocytes in immune checkpoint inhibitor-related pneumonitis
16. Dysregulation of the kallikrein-kinin system in bronchoalveolar lavage fluid of patients with severe COVID-19
17. The pulmonary vasculature in lethal COVID-19 and idiopathic pulmonary fibrosis at single-cell resolution
18. Targeting C5aR1 signaling reduced neutrophil extracellular traps and ameliorates COVID-19 pathology
19. Pan-Cancer Detection and Typing by Mining Patterns in Large Genome-Wide Cell-Free DNA Sequencing Datasets
20. Lung Aeration in COVID-19 Pneumonia by Ultrasonography and Computed Tomography
21. Targeted RNA sequencing for upfront analysis of actionable driver alterations in non-small cell lung cancer
22. Pan-cancer detection and typing by mining patterns in large genome-wide cell-free DNA sequencing datasets
23. Atypical response to bacterial coinfection and persistent neutrophilic bronchoalveolar inflammation distinguish critical COVID-19 from influenza
24. Acute kidney injury in patients treated with immune checkpoint inhibitors
25. Persistence of SARS-CoV-2 RNA in lung tissue after mild COVID-19
26. Genome-wide CRISPR screening identifies TMEM106B as a proviral host factor for SARS-CoV-2
27. The Role of Flexible Bronchoscopy in Swab-negative Patients During the SARS-CoV2 Pandemic
28. Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity
29. Establishing a Unified COVID-19 “Immunome”: Integrating Coronavirus Pathogenesis and Host Immunopathology
30. A pan-cancer blueprint of the heterogeneous tumor microenvironment revealed by single-cell profiling
31. Programmed death-ligand 1 expression influenced by tissue sample size. Scoring based on tissue microarrays' and cross-validation with resections, in patients with, stage I–III, non-small cell lung carcinoma of the European Thoracic Oncology Platform Lungscape cohort
32. A Pan-cancer Blueprint of the Heterogeneous Tumour Microenvironment Revealed by Single-Cell Profiling
33. An Integrated Gene Expression Landscape Profiling Approach to Identify Lung Tumor Endothelial Cell Heterogeneity and Angiogenic Candidates
34. An Integrated Gene Expression Landscape Profiling Approach to Identify Lung Tumor Endothelial Cell Heterogeneity and Angiogenic Candidates
35. Monocyte-Driven Atypical Cytokine Storm and Aberrant Neutrophil Activation as Key Mediators of COVID19 Disease Severity
36. Pembrolizumab-induced necrotizing myositis in a patient with metastatic non-small-cell lung cancer: a case report
37. Capmatinib for the treatment of non-small cell lung cancer
38. Author Correction: CPS1 maintains pyrimidine pools and DNA synthesis in KRAS/LKB1-mutant lung cancer cells
39. Subsequent Event Risk in Individuals With Established Coronary Heart Disease
40. Cigarette Smoke–Induced Emphysema Exhausts Early Cytotoxic CD8+ T Cell Responses against Nascent Lung Cancer Cells
41. RNA-sequencing in non-small cell lung cancer shows gene downregulation of therapeutic targets in tumor tissue compared to non-malignant lung tissue
42. Phenotype molding of stromal cells in the lung tumor microenvironment
43. Evaluation of NGS and RT-PCR Methods for ALK Rearrangement in European NSCLC Patients: Results from the European Thoracic Oncology Platform Lungscape Project
44. Immunotherapy in non-metastatic non-small cell lung cancer: Can the benefits of stage IV therapy be translated into earlier stages?
45. A Randomized Clinical Trial of Flex 19G Needles versus 22G Needles for Endobronchial Ultrasonography in Suspected Lung Cancer
46. Impact of Selection Bias on Estimation of Subsequent Event Risk
47. Do COPD subtypes really exist? COPD heterogeneity and clustering in 10 independent cohorts
48. CPS1 maintains pyrimidine pools and DNA synthesis in KRAS/LKB1-mutant lung cancer cells
49. Prospects and progress of atezolizumab in non-small cell lung cancer
50. SC22.01 How Do I Define Optimal Candidates for Immunotherapy in My Practice?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.